₹15,662 crore due to a correction from the slump that was witnessed in the corresponding month last year and also because the sharp surge in covid-19 cases in the second wave boosted demand, data from market research firm AIOCD-AWACS showed.“Covid second wave has further boosted the sales of drugs having direct/indirect role in treatment.